Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effect of oxygen on antimicrobial resistance genes from a one health perspective

  • Ortiz-Miravalles, Laura
  • Prieto, Amalia
  • Kieffer, Nicolas
  • Vergara, Ester
  • Cantón, Rafael
  • San Millán, Álvaro
  • Baquero, Fernando
  • Hipólito, Alberto
  • Escudero, José Antonio
Supplementary data to this article can be found online at https://doi.org/10.1016/j.scitotenv.2025.179523, Bacteria must face and adapt to a variety of physicochemical conditions in the environment and during infection. A key condition is the concentration of dissolved oxygen, proportional to the partial pressure of oxygen (PO2), which is extremely variable among environmental biogeographical areas and also compartments of the human and animal body. Here, we sought to understand if the phenotype of resistance determinants commonly found in Enterobacterales can be influenced by oxygen pressure. To do so, we have compared the MIC in aerobic and anaerobic conditions of isogenic Escherichia coli strains containing 136 different resistance genes against 8 antibiotic families. Our results show a complex landscape of changes in the performance of resistance genes in anaerobiosis. Certain changes are especially relevant for their intensity and the importance of the antibiotic family, like the large decreases in resistance observed against ertapenem and fosfomycin among blaVIM β-lactamases and certain fos genes, respectively; however, the blaOXA-48 β-lactamase from the clinically relevant pOXA-48 plasmid conferred 4-fold higher ertapenem resistance in anaerobiosis. Strong changes in resistance patterns in anaerobiosis were also conserved in Klebsiella pneumoniae. Our results suggest that anaerobiosis is a relevant aspect that can affect the action and selective power of antibiotics for specific AMRs in different environments., The work in the MBA laboratory is supported by the European Research Council (ERC) through a Starting Grant [ERC grant no. 803375-KRYPTONINT] and the Ministerio de Ciencia e Innovación [PID2020-117499RB-100 and CNS2022-135857]; and the EU HARISSA JPI-AMR program [PCI2021-122024-2A]. J.A.E. has been supported by the Atracción de Talento Program of the Comunidad de Madrid [2020-5A/BIO19726]; L.O. is supported by a grant from the Ministerio de Universidades (FPU21/03268). N.K. is supported by EU’s Horizon 2020 Marie Skłodowska-Curie – UNA4CAREER grant (N◦: 847635). A.H. is supported by the PhD program at UCM., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mobile integrons encode phage defense systems

  • Kieffer, Nicolas
  • Hipólito, Alberto
  • Ortiz-Miravalles, Laura
  • Blanco, Paula
  • Delobelle, Thomas
  • Vizuete, Patricia
  • Ojeda, Francisco Manuel
  • Jové, Thomas
  • Jurenas, Dukas
  • García-Quintanilla, Meritxell
  • Carvalho, André
  • Domingo-Calap, Pilar
  • Escudero, José Antonio
Integrons are bacterial genetic elements that capture, stockpile,and modulate the expression of genes encoded in integroncassettes. Mobile integrons (MIs) are borne on plasmids, actingas a vehicle for hundreds of antimicrobial resistance genesamong key pathogens. These elements also carry genecassettes of unknown function (gcus) whose role and adaptivevalue remain unexplored. In this work, we show that gcusencode phage resistance systems, many of which are newlydiscovered. Bacteriophage resistance integron cassettes(BRiCs) can be combined and mixed with resistance cassettesto produce multiphage or drug and phage resistance. Thefitness costs of BRiCs are variable and dependent on thegenetic context and can be modulated by changing the order ofcassettes in the array. Hence, MIs act as highly mobile, low-costdefense islands., European Union’s Horizon 2020 Marie Skłodowska-Curie grant agreement no. 847635 (N.K.); Universidad Complutense PhD program (A.H.); Juan de la Cierva program FJC 2020-043017-I (P.B.); Ministerio de Ciencia, Innovación yUniversidades FPU21/03268 (L.O.M.); Ministerio de Ciencia e Innovación Programa Ramón y Cajal RYC2019-028015-I (P.D.-C.); Ministerio de Ciencia e Innovación PID2020-112835RA-I00 (P.D.-C.); Ministerio de Ciencia e Innovación Subprograma Miguel Servet CP19/00104 (M.G.-Q.); Instituto de Salud Carlos III (Plan Estatal de I+D+i2017–2020) (M.G.-Q.); European Research Council (ERC) Starting Grant (803375)(J.A.E.); Ministerio de Ciencia, Innovación y Universidades BIO2017-85056-P (J.A.E.); Ministerio de Ciencia, Innovación y Universidades CNS2022-135857 (J.A.E.); Ministerio de Ciencia e Innovación PID2020-117499RB-100 (J.A.E.); EU HARISSA JPI-AMR program PCI2021-122024-2A (J.A.E.); Comunidad de Madrid Programa de Atracción de Talento2016-T1/BIO-1105 (J.A.E.); Comunidad de Madrid Programa de Atracción de Talento2020-5A/BIO-19726 (J.A.E.)., Peer reviewed